Provided by Tiger Trade Technology Pte. Ltd.

Oncolytics Biotech Inc

0.7768
-0.0182-2.29%
Volume:3.41M
Turnover:2.74M
Market Cap:99.05M
PE:-2.42
High:0.8274
Open:0.7934
Low:0.7704
Close:0.7950
52wk High:1.51
52wk Low:0.7301
Shares:127.51M
Float Shares:122.97M
Volume Ratio:4.51
T/O Rate:2.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3215
EPS(LYR):-0.3000
ROE:-10187.64%
ROA:-211.24%
PB:-16.06
PE(LYR):-2.59

Loading ...

Apr 01, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 31, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 20, 2026

Major Issues Report

Form 8-K - Current report
Mar 19, 2026

Major Issues Report

Form 8-K - Current report
Mar 02, 2026

Major Issues Report

Form 8-K - Current report
Feb 24, 2026

Major Issues Report

Form 8-K - Current report
Feb 04, 2026

Major Issues Report

Form 8-K - Current report
Jan 15, 2026

Major Issues Report

Form 8-K - Current report
Jan 15, 2026

Major Issues Report

Form 8-K - Current report
Jan 12, 2026

Major Issues Report

Form 8-K - Current report
Jan 09, 2026

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Dec 06, 2025

Correspondence

Form CORRESP - Correspondence
Aug 28, 2025

Correspondence

Form CORRESP - Correspondence
Mar 07, 2025

Annual Report

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Jun 04, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 12, 2024

Annual Report

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Mar 03, 2023

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Mar 03, 2022

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Mar 05, 2021

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Mar 05, 2021

important event

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]